The discovery of GLP-1R/GcgR dual agonists has provided a fresh medicinal approach and renewed hope that obesity and its associated abnormalities might be managed with medicines as opposed to surgical interventions
Ongoing research continues to elucidate the full extent of these benefits, underscoring the importance of personalised medical advice in treatment planning
Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulphide (GSSG) in biological samples: an elephant in the room
Program details may vary based on the patients clinical profile, provider recommendation, pharmacy preparation, treatment response, and wellness goals
Methods This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify and evaluate in vitro studies investigating the effects of glucagon-like peptide-1 receptor agonists and their analogues on human mesenchymal stem cell functions, including proliferation, differentiation, signaling, apoptosis, and tissue-specific applications
Health intelligence made simple, accessible, and remarkably effective